December 22, 2008 - A Swiss cancer clinic is among the first in the world to use the newest radiotherapy technology from Varian Medical Systems, RapidArc, to treat a child patient.

A 12-year-old girl with Hodgkin's lymphoma was treated using Varian's RapidArc technique at the Istituto Oncologico della Svizzera Italiana (IOSI) in Bellinzona, southern Switzerland.

The girl received her targeted radiotherapy dose in less than two and a half minutes, using two continuous revolutions of the device while she lay on the treatment machine. The RapidArc treatment was reportedly faster than would have been possible with conventional intensity modulated radiotherapy
(IMRT) treatments, which are slower and more difficult for radiotherapy radiographers because they target tumors using a complex sequence of fixed beams from multiple angles.

"Treating children with cancer is always challenging, but RapidArc enables us to deliver extremely precise treatments much more quickly than would have been possible previously, making it a much more comfortable experience for the patient while minimizing damage to healthy tissue," said radiation
oncologist Dr. Alessandra Franzetti-Pellanda. "Faster treatments mean there is less chance for the patient to move during delivery, which helps precision. It can also be uncomfortable lying on the couch so to be able to reduce the time of treatment while enhancing the precision is tremendously helpful." Dr. Franzetti-Pellanda worked with head medical physicist Dr. Antonella Fogliata and medical oncologist Dr. Pierluigi Brazzola to carry out the pioneering treatment.

IOSI became the first hospital in Switzerland to commence treatments using RapidArc in November. The hospital treats 700 patients a year on two Varian Clinac medical linear accelerators and RapidArc volumetric modulated arc therapy (VMAT) capability has been added to one of these machines.

For more information: www.varian.com


Related Content

News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Intensity Modulated Radiation Therapy (IMRT)

March 14, 2022 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time March 14, 2022
arrow
News | Intensity Modulated Radiation Therapy (IMRT)

October 22, 2021 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a ...

Time October 22, 2021
arrow
News | Intensity Modulated Radiation Therapy (IMRT)

October 27, 2020 — A preliminary analysis of photon therapy treatment group 1 from the phase II NRG Oncology clinical ...

Time October 27, 2020
arrow
News | Radiation Therapy

June 10, 2020 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...

Time June 10, 2020
arrow
News | Radiation Therapy

April 16, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time April 16, 2020
arrow
News | Proton Therapy

January 29, 2020 — IBA (Ion Beam Applications S.A.) announced that it has signed a contract and received a major down ...

Time January 29, 2020
arrow
Technology | Image Guided Radiation Therapy (IGRT)

Accuray announced the launch of its Synchrony motion tracking and correction technology to be used with the Radixact System. This new feature adds intrafraction motion synchronization capabilities to the Radixact System, enabling real-time tracking, visualization and correction for tumor motion during treatment, with the goal of improving dose accuracy and treatment times compared to conventional radiation therapy systems. The Radixact System with Synchrony will be unveiled at the European Society for Radiotherapy & Oncology (ESTRO) meeting, April 26-30 in Milan, Italy.

Time April 24, 2019
arrow
News | Intensity Modulated Radiation Therapy (IMRT)

An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with hypofractionated intensity modulated radiation therapy (HIMRT) yields equivalent disease outcomes compared with conventional intensity modulated radiation (CIMRT). It is the largest randomized single-institution study with the longest follow-up period on this topic to date.

Time October 31, 2018
arrow
News | Proton Therapy

IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the Proteus One proton therapy solution in Japan. The first installation took place at the Hokkaido Ohno Memorial Hospital in Sapporo and the other at the Narita Memorial Proton Center in Toyohashi. Both installations were successful, according to the company, as the Hokkaido Ohno Memorial Hospital installation took less than 12 months and the Narita Memorial Proton Center installation took less than 11 months.

Time July 30, 2018
arrow
Subscribe Now